Published in Blood Weekly, October 30th, 2003
"Indications for apheresis may vary and more than 45 different diagnoses have been reported from various countries," scientists in Sweden explained. "New devices are being developed and, in the beginning their clinical implications and use are limited to detect rare but important side effects."
"However, to achieve more reliable information on the effects and side effects we need more extensive sampling of data," argued B. Stegmayr and colleagues at the University of Umea Hospital.
"Collection of such data is considered a safety and quality issue in several...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.